Cochrane Abstracts
Anti‐vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Anti‐vascular Endothelial Growth Factor for Macular Oedema Secondary to Branch Retinal Vein Occlusion." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433643/all/Lithium_for_schizophrenia_New_search_for_studies_and_content_updated__no_change_to_conclusions_. Accessed 09 June 2023.
Anti‐vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433643/all/Lithium_for_schizophrenia_New_search_for_studies_and_content_updated__no_change_to_conclusions_. Accessed June 9, 2023.
Anti‐vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433643/all/Lithium_for_schizophrenia_New_search_for_studies_and_content_updated__no_change_to_conclusions_
Anti‐vascular Endothelial Growth Factor for Macular Oedema Secondary to Branch Retinal Vein Occlusion [Internet]. In: Cochrane Abstracts. [cited 2023 June 09]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433643/all/Lithium_for_schizophrenia_New_search_for_studies_and_content_updated__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Anti‐vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion
ID - 433643
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433643/all/Lithium_for_schizophrenia_New_search_for_studies_and_content_updated__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -
